Yoshihiro Kumagae Selected Research

4- ((1S)- methylamino- 3- (4- nitrophenoxy))propylphenyl N,N-dimethylcarbamate

9/2003

Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Kumagae Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 09/2003 - 11/2002
2	Obesity 03/2011 - 03/2009
2	Insulin Resistance 03/2011 - 03/2009
1	Morbid Obesity 03/2011
1	Hyperphagia (Overeating) 03/2011
1	Type 2 Diabetes Mellitus (MODY) 03/2009
1	Hyperglycemia 03/2009
1	Cognitive Dysfunction 09/2003
1	Amyloid Plaque 11/2002

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 03/2011 - 03/2009
2	Amyloid beta-PeptidesIBA 03/2003 - 11/2002
1	Aurothioglucose (Gold 50)IBA 03/2011
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2009
1	Hemoglobin AIBA 03/2009
1	4- ((1S)- methylamino- 3- (4- nitrophenoxy))propylphenyl N,N-dimethylcarbamateIBA 09/2003
1	AcetylcholinesteraseIBA 09/2003
1	Cholinergic Agents (Cholinergics)IBA 09/2003
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 09/2003
1	RHO(D) antibody (anti-D)IBA 11/2002
1	AntigensIBA 11/2002
1	AntibodiesIBA 11/2002